Jianming Ye

Dr. Jianming Ye

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
JWJianqing Wang
Jianqing Wang
WMWeitao Mo
Weitao Mo
YWYan Wu
Yan Wu
XXXiaomei Xu
Xiaomei Xu
YLYi Li
Yi Li
XLXiaobo Lai
Xiaobo Lai
Chinese Herbal Slices (CHS) are critical components of Traditional Chinese Medicine (TCM); the accurate recognition of CHS is crucial for applying to medicine, production, and education. However, existing methods to recognize the CHS are mainly performed by experienced professionals, which may not meet vast CHS market demand due to time-consuming and the limited number of professionals. Although some automated CHS recognition approaches have been proposed, the performance still needs further improvement because they are primarily based on the traditional machine learning with hand-crafted features, resulting in relatively low accuracy. Additionally, few CHS datasets are available for research aimed at practical application. To comprehensively address these problems, we propose a combined channel attention and spatial attention module network (CCSM-Net) for efficiently recognizing CHS with 2-D images. The CCSM-Net integrates channel and spatial attentions, focusing on the most important information as well as the position of the information of CHS image. Especially, pairs of max-pooling and average pooling operations are used in the CA and SA module to aggregate the channel information of the feature map. Then, a dataset of 14,196 images with 182 categories of commonly used CHS is constructed. We evaluated our framework on the constructed dataset. Experimental results show that the proposed CCSM-Net indicates promising performance and outperforms other typical deep learning algorithms, achieving a recognition rate of 99.27%, a precision of 99.33%, a recall of 99.27%, and an F1-score of 99.26% with different numbers of CHS categories.

26 November 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
BKBoyang Kuang
Boyang Kuang
KYKuan Yang
Kuan Yang
XZXiaoting Zhong
Xiaoting Zhong
YTYingwei Tan
Yingwei Tan
YZYi Zhou
Yi Zhou
JYJianming Ye
Jianming Ye
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has emerged as a multifaceted therapeutic agent in oncology due to its dual anti-inflammatory and antitumor properties. This review synthesizes recent advances in understanding the molecular mechanisms and clinical applications of celecoxib in cancer treatment. Celecoxib not only hinders the proliferation and metastasis of tumor cells by inhibiting COX-2 synthesis, but also inhibits the intratumoral infiltration of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) and activates cytotoxic T cells, thereby reshaping the inhibitory immune microenvironment. Preclinical and clinical studies demonstrate its synergistic effects with chemotherapy, radiotherapy, and immunotherapy, particularly in augmenting immune checkpoint blockade efficacy. Despite the breakthrough of celecoxib in the field of oncology treatment, large-scale trials are warranted to validate its long-term safety and biomarker-driven accuracy. This work underscores the potential of celecoxib as a cornerstone in multimodal cancer therapy and provides a roadmap for its integration into personalized treatment paradigms.

22 April 2021 in Scientific Programming
Verified
Journal Article
Open access
PDF file
JYJianming Ye
Jianming Ye
HHHe Huang
He Huang
WJWeiwei Jiang
Weiwei Jiang
XXXiaomei Xu
Xiaomei Xu
CXChun Xie
Chun Xie
XLXiaobo Lai
Xiaobo Lai
Glioma is one of the most common and deadly malignant brain tumors originating from glial cells. For personalized treatment, an accurate preoperative prognosis for glioma patients is highly desired. Recently, various machine learning-based approaches have been developed to predict the prognosis based on preoperative magnetic resonance imaging (MRI) radiomics, which extract quantitative features from radiographic images. However, major challenges remain for methodologic developments to optimize feature extraction and provide rapid information flow in clinical settings. This study investigates two machine learning-based prognosis prediction tasks using radiomic features extracted from preoperative multimodal MRI brain data: (i) prediction of tumor grade (higher-grade vs. lower-grade gliomas) from preoperative MRI scans and (ii) prediction of patient overall survival (OS) in higher-grade gliomas ( 12 months) from preoperative MRI scans. Specifically, these two tasks utilize the conventional machine learning-based models built with various classifiers. Moreover, feature selection methods are applied to increase model performance and decrease computational costs. In the experiments, models are evaluated in terms of their predictive performance and stability using a bootstrap approach. Experimental results show that classifier choice and feature selection technique plays a significant role in model performance and stability for both tasks; a variability analysis indicates that classification method choice is the most dominant source of performance variation for both tasks.

14 April 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
JYJianming Ye
Jianming Ye
XXXiaomei Xu
Xiaomei Xu
LLLiuyi Li
Liuyi Li
JZJialu Zhao
Jialu Zhao
WLWeiling Lai
Weiling Lai
XLXiaobo Lai
Xiaobo Lai
Intracranial aneurysms are local dilations of the cerebral blood vessels; people with intracranial aneurysms have a high risk to cause bleeding in the brain, which is related to high mortality and morbidity rates. Accurate detection and segmentation of intracranial aneurysms from Magnetic Resonance Angiography (MRA) images are essential in the clinical routine. Manual annotations used to assess the intracranial aneurysms on MRA images are substantial interobserver variability for both aneurysm detection and assessment of aneurysm size and growth. Many prior automated segmentation works have focused their efforts on tackling the problem, but there is still room for performance improvement due to the significant variability of lesions in the location, size, structure, and morphological appearance. To address these challenges, we propose a novel One-Two-One Fully Convolutional Networks (OTO-Net) for intracranial aneurysms automated segmentation in MRA images. The OTO-Net uses full convolution to achieve intracranial aneurysms automated segmentation through the combination of downsampling, upsampling, and skip connection. In addition, loss ensemble is used as the objective function to steadily improve the backpropagation efficiency of the network structure during the training process. We evaluated the proposed OTO-Net on one public benchmark dataset and one private dataset. Our proposed model can achieve the automated segmentation accuracy with 98.37% and 97.86%, average surface distances with 1.081 and 0.753, dice similarity coefficients with 0.9721 and 0.9813, and Hausdorff distance with 0.578 and 0.642 on these two datasets, respectively.

2 February 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
JYJianming Ye
Jianming Ye
WYWeiji Yang
Weiji Yang
JWJianqing Wang
Jianqing Wang
XXXiaomei Xu
Xiaomei Xu
LLLiuyi Li
Liuyi Li
XLXiaobo Lai
Xiaobo Lai
To overcome the limitations of conventional breast screening methods based on digital mammography, a quasi-3D imaging technique, digital breast tomosynthesis (DBT) has been developed in the field of breast cancer screening in recent years. In this work, a computer-aided architecture for mass regions segmentation in DBT images using a dilated deep convolutional neural network (DCNN) is developed. First, to improve the low contrast of breast tumour candidate regions and depress the background tissue noise in the DBT image effectively, the constraint matrix is established after top-hat transformation and multiplied with the DBT image. Second, input image patches are generated, and the data augmentation technique is performed to create the training data set for training a dilated DCNN architecture. Then the mass regions in DBT images are preliminarily segmented; each pixel is divided into two different kinds of labels. Finally, the postprocessing procedure removes all false-positives regions with less than 50 voxels. The final segmentation results are obtained by smoothing the boundaries of the mass regions with a median filter. The testing accuracy (ACC), sensitivity (SEN), and the area under the receiver operating curve (AUC) are adopted as the evaluation metrics, and the ACC, SEN, as well as AUC are 86.3%, 85.6%, and 0.852 for segmenting the mass regions in DBT images on the entire data set, respectively. The experimental results indicate that our proposed approach achieves promising results compared with other classical CAD-based frameworks.

4 June 2024 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
LHLi Huang
Li Huang
XZXiaoting Zhong
Xiaoting Zhong
ALAn Li
An Li
FTFuping Tu
Fuping Tu
MHMiao He
Miao He
JYJianming Ye
Jianming Ye
Background: Syntaxin6 (STX6) is a SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein complex located in the trans-Golgi network and endosomes, which is closely associated with a variety of intracellular membrane transport events. STX6 has been shown to be overexpressed in a variety of human malignant tumors such as esophageal, colorectal, and renal cell carcinomas, and participates in tumorigenesis and development. Methods: Based on clinical public database and clinical liver samples analysis, the expression of STX6 in hepatocellular carcinoma (HCC) tissues was investigated. The effects of STX6 on proliferation, migration and invasion of HCC cell in vitro and in vivo were evaluated through gain- and loss-of-function studies. We further performed RNA-seq analysis and protein interactome analysis, to further decifer the detailed mechanisms of STX6 in the regulation of the JAK-STAT pathway in HCC. Results: STX6 expression was upregulated in HCC tissues and its expression was highly correlated with the high histological grade of the tumor. STX6 promoted HCC cell proliferation, migration and invasion both in vitro and in vivo. Mechanistically, STX6 mediated tumor progression depending on promoting the activation of JAK-STAT signaling pathway. Receptor for activated protein kinase C (RACK1) as an essential adaptor protein mediating STX6 regulation of JAK-STAT pathway. Specifically, STX6 interacted with RACK1 and then recruited signal transducer and activator of transcription 3 (STAT3) to form a protein-binding complex and activates STAT3 transcriptional activity. Conclusions: This study provided a novel concept that STX6 exerted oncogenic effects by activating the STAT3 signaling pathway, and STX6 might be a promising therapeutic target for HCC.